US63009J1079 - ADR
NANOBIOTIX SA - ADR
NASDAQ:NBTX (3/28/2024, 8:26:37 PM)
6.4999
+0.15 (+2.36%)
Nanobiotix SA is a late-stage biotechnology company, which engages in the development of therapeutic approaches to the treatment of cancer. The company is headquartered in Paris, Ile-De-France and currently employs 101 full-time employees. The company went IPO on 2012-10-29. The firm designs and manufactures nanoparticles that safely enhance the efficacy of radiation therapy in the treatment of cancer. The company develops new tools for cancer that utilize a physical mode of action at the cellular level of the cancer cell. The firm's NanoXray technology comprises three products. Local treatment (surgery and radiotherapy) provides potential cure and gives the systemic treatment a better chance to life expectancy. NanoXray products are developed for the efficacy of radiotherapy in the tumor cell. Nanobiotix is a spin-off of the State University of New York (SUNY) at Buffalo.
NANOBIOTIX SA - ADR
60 rue de Wattignies
Paris ILE-DE-FRANCE 75012
P: 33140260470
CEO: Dr. Laurent Levy
Employees: 101
Website: https://www.nanobiotix.com
Pre-market stock movers are the perfect way to start the week as we dive into the biggest stories moving shares on Monday!
PARIS and CAMBRIDGE, Mass., March 06, 2024 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ‘‘Company’’), a late-clinical stage...
PARIS et CAMBRIDGE, Mass., 06 mars 2024 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext : NANO –– NASDAQ : NBTX – la « Société »), société française de...
Here you can normally see the latest stock twits on NBTX, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: